Abstract
Novel technology allows for implantable neurostimulators (INS) to deliver therapeutic stimulation as well as record brain sensing information that can provide objective data to help optimize treatment. Local field potential (LFP) signals have been shown to be related to Parkinson’s disease (PD) symptoms, where LFP beta oscillations (13-30 Hz) tend to reflect rigidity and LFP gamma oscillations (48-200 Hz) tend to reflect dyskinesias1. A series of case studies were examined to detail in-clinic approaches to deep brain stimulation (DBS) programming that are informed by brain recordings of LFP.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Neuromodulation: Technology at the Neural Interface
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
